Align Technology, Inc. vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
7.1
Bullish
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
ALGN
Clean balance sheet with low leverage (0.0× debt-to-equity).
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
BUY
Target $209.00 (+16.8%)
14 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
ALGN
JNJ
30.0×
Trailing P/E
26.3×
14.5×
Forward P/E
17.9×
10.5%
Profit Margin
21.8%
70.5%
Gross Margin
68.0%
10.8%
ROE
26.4%
6.2%
Revenue Growth
9.9%
23.9%
Earnings Growth
-52.9%
1.81
Beta
0.33
—
Price / Book
—
$12.8B
Market Cap
$546.9B
$122 – $208
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →